fenspiride
Enable an agent to recognise fenspiride, assess the identity and condition of a material sample, and determine which handling or use decisions require chemical, safety or regulatory evidence.
Bundle → Layer → Finding → Questions Filled
6 bundles · 11 layers · 19 findings · 29 questions
Fenspiride identity and form Establish which molecular entity and material form a fenspiride record represents.
Parent structure
Anchor the registry entry to molecular connectivity.
Structure-backed identification
Recognition requires agreement between the claimed fenspiride identity, a structural reference and sample evidence appropriate to the task.
- Which structural identifier anchors this record to the fenspiride parent? definition
- Which analytical evidence supports the sample's claimed molecular identity? measurement
Salt and product boundaries
Keep material form and containing products explicit.
Counterion and composition
Counterions, water, solvents and excipients must be distinguished from the parent molecular identity.
- Is the material the free base, hydrochloride or another analytically established form? boundary
- Does the record describe isolated substance material or a finished preparation requiring a linked product model? boundary
Fenspiride material quality Assess what a particular material lot contains and whether its evidence supports the intended use.
Assay and equivalence
Interpret content measurements against the actual material composition.
Explicit content basis
Keep measured mass content separate from chromatographic area percentage and make salt-to-parent conversions auditable.
- Does the reported assay measure mass content, molar content or chromatographic area percentage? measurement
- Which counterion stoichiometry, water correction and reference-standard assignment support any parent-equivalent calculation? provenance
Impurities and suitability
Connect impurity evidence to a defined intended use.
Qualified lot assessment
Suitability depends on documented criteria and the method's ability to detect relevant non-fenspiride components.
- Which impurities, residual solvents and unidentified peaks were measured, and with what reporting limits? measurement
- Which specification supports accepting this lot for the proposed analytical or research use? action
Fenspiride physical state and stability Capture properties and changes of the identified material under explicit conditions.
Conditional physical properties
Describe solid-state, thermal and solution behaviour without merging incompatible measurements.
Form-matched property evidence
A property value is usable only when its material form, conditions and measurement status are known.
- Which solid form and experimental conditions underlie each thermal or solubility value? measurement
- Were pH-dependent solution properties measured for the parent, the hydrochloride or another preparation? boundary
Storage and change
Determine whether current material remains covered by earlier quality evidence.
Evidence-supported retest
Storage decisions require documented exposure history and appropriate evidence of chemical or physical change.
- What stability data support the assigned storage conditions and retest interval for this form? provenance
- Which observed changes or storage excursions require repeat identity, assay or impurity testing? action
Fenspiride biological and cardiac evidence Represent biological claims and cardiac safety findings with their experimental and clinical limits.
Pharmacological claim context
Separate measured effects, proposed mechanisms and historical therapeutic uses.
Traceable biological claims
Each pharmacological claim needs its own endpoint, material identity and evidence context.
- Which primary studies support each proposed receptor, anti-inflammatory or respiratory effect? provenance
- What test system, material form and concentration or exposure produced the reported effect? measurement
Cardiac safety signal
Preserve evidence relevant to repolarisation and arrhythmia risk.
QT and proarrhythmia evidence
EMA's review linked fenspiride to QT prolongation and proarrhythmic potential, including torsades de pointes, drawing on clinical reports and nonclinical evidence including hERG studies. [EMA referral](https://www.ema.europa.eu/en/medicines/human/referrals/fenspiride-containing-medicinal-products)
- Which clinical reports and nonclinical studies support each cardiac endpoint, and what limitations do they report? provenance
- How should the documented cardiac signal constrain evaluation of the proposed use without inventing a safe exposure threshold? action
Fenspiride restrictions and handling Connect regulatory history and material hazards to the exact proposed activity.
Medicinal regulatory history
Record dated decisions and the products and activities they cover.
Jurisdiction-specific withdrawal
In May 2019, EMA's safety committee recommended revoking marketing authorisations for fenspiride medicines because of heart rhythm risks; the record must preserve the decision's jurisdiction, procedural stage and product scope. [EMA referral](https://www.ema.europa.eu/en/medicines/human/referrals/fenspiride-containing-medicinal-products)
- Which authoritative decision establishes the applicable status, effective date and affected products in the target jurisdiction? provenance
- Does that decision govern the proposed activity, or is separate evidence needed for research supply, import or possession? boundary
Material handling controls
Determine applicable controls for the identified form and condition.
Form-specific hazard evidence
Use current, applicable hazard documentation for the material rather than inferring GHS classes or occupational limits from medicinal safety findings.
- Which current safety data sheet and authoritative classification apply to this form, concentration and jurisdiction? provenance
- Which documented controls govern handling, storage, transport and disposal for the proposed activity? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these check these first hold for the sense of fenspiride this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these kinds and varieties hold for the sense of fenspiride this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these identifiers and schemes hold for the sense of fenspiride this model covers, and on what evidence? provenance
Standards and regulation
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these standards and regulation hold for the sense of fenspiride this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these real-world use hold for the sense of fenspiride this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these typical measurements hold for the sense of fenspiride this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these failure modes and hazards hold for the sense of fenspiride this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these regional variation hold for the sense of fenspiride this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of fenspiride this model covers, and on what evidence? provenance
Classifiers Filled
- Family
- Thing Registry
- Category
- Physical world and living systems
- Entry kind
- thing
- Plane
- PHY
- Domain
- PHY.MAT
What it is Filled
Fenspiride is a synthetic spirocyclic pharmaceutical substance formerly used for respiratory symptoms because of its anti-inflammatory and bronchoconstriction-reducing effects, but withdrawn in the European Union because of cardiac rhythm risks.
In scope
- Fenspiride molecular identity and evidence-backed identifier mappings
- Free-base versus salt form, composition, purity and analytical identity
- Physical state, solubility, thermal behaviour and storage stability under recorded conditions
- Substance-level pharmacological and cardiac safety evidence
- Jurisdiction-, date- and activity-specific restrictions relevant to handling or use
Out of scope
- Finished medicine formulations, brands, packaging and product authorisations as independent entities
- Patient diagnosis, prescribing, dosing and treatment selection
- Manufacturing routes, production equipment and process optimisation
- Respiratory diseases and cardiac disorders as disease models
- Independent models for impurities, metabolites and analytical reference materials
Why it exists Filled
Enable an agent to recognise fenspiride, assess the identity and condition of a material sample, and determine which handling or use decisions require chemical, safety or regulatory evidence.
Distinguishing features Filled
- Match molecular connectivity to 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one rather than accepting a respiratory-drug label as identity. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Fenspiride)
- For the neutral parent, check agreement with formula C15H20N2O2, PubChem CID 3344 and InChIKey FVNFBBAOMBJTST-UHFFFAOYSA-N; formula alone is insufficient. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Fenspiride)
- Distinguish the parent from fenspiride hydrochloride by counterion evidence: PubChem represents the hydrochloride separately as CID 68626 with formula C15H21ClN2O2. [PubChem hydrochloride](https://pubchem.ncbi.nlm.nih.gov/compound/68626)
- Distinguish isolated fenspiride material from a containing medicine by the presence of excipients, other ingredients and a finished-product identity.
What robots and AI may and may not do Filled
Must not
- Recommend, supply or dose it for anyone, including children.
- Help obtain it from sources where it has been withdrawn.
- Downplay the heart rhythm risk behind its withdrawal.
Only with a human decision
- Any decision about treating cough or respiratory illness.
May
- Describe fenspiride's former uses and why it was withdrawn in the European Union.
- Warn people who still hold old stock that it is no longer recommended.
Moral aspects Filled
- It was widely given to children for minor illness; withdrawal shows the duty to act on safety signals.
Who is affected
- Children and parents
- Patients
- Pharmacists
Owners Filled
Steward
Medicines regulators decide its status; marketing authorisation holders answer for stock where it remains licensed.
Master systems
- National medicines registers
Links to other meta-models Filled
parent
- Q11173 - registry parent class
What else AI and robots need to interact with it Filled
Identity and identifiers required Filled
- Vercy registry: vr.tr.fenspiride
- Wikidata: Q518027 (https://www.wikidata.org/wiki/Q518027)
Direct properties required Filled
- Molecular identity: Verified structure identifier and parent-compound identifier; matched, conflicting or unresolved
- Material form: Free base, hydrochloride, other evidenced salt, mixture or unresolved; hydration and solvation recorded separately
- Fenspiride content: % mass fraction or mg/g, with as-is or dry basis and parent-equivalent or salt basis
- Impurity and residual-solvent profile: Identity and concentration in % or mg/kg, with method, detection limits and unidentified components
- Physical and solid-state condition: Observed phase, crystalline or amorphous character, evidenced solid form, temperature in °C and pressure in kPa
- Conditional solubility and ionisation: Solubility in mg/mL or mol/L with solvent, pH, temperature and material form; pKa with method and conditions
- Thermal behaviour: Melting, transition or decomposition temperature in °C with method; boiling point only if experimentally applicable
- Stability qualification: Supported within tested conditions, changed, outside qualification or unknown; linked storage history and retest date
- Biological evidence context: Linked study, endpoint, test system, concentration or exposure, material form and evidence limitations
- Handling hazard classification: Form-specific GHS classification, jurisdiction, source and revision date; exposure limit with units or explicitly unestablished
- Regulatory applicability: Authority, jurisdiction, affected product or substance, activity, decision, effective date and verification date
Recognition required Filled
- Was supplied as syrups or tablets; identity is confirmed by label and pharmacy records.
Capabilities and actions required Filled
- Resolve a name or supplier record to the parent structure and flag salt or identifier conflicts.
- Compare analytical results with a stated material specification and identify missing identity or quality evidence.
- Convert salt-basis content to parent-equivalent content when composition, stoichiometry and assay basis are established.
- Select form- and condition-matched property evidence for a proposed analysis or solution preparation.
- Flag proposed uses requiring review of cardiac safety evidence or jurisdiction-specific restrictions.
- Route uncertain, degraded or out-of-specification material for further testing, quarantine or an applicable disposal procedure.
Hazards and failure modes required Filled
- Can prolong the QT interval and trigger dangerous heart rhythms.
Standards and interfaces required Filled
- The Anatomical Therapeutic Chemical classification maintained by the WHO Collaborating Centre for Drug Statistics Methodology assigns fenspiride code R03DX03 under other systemic drugs for obstructive airway diseases.
Context of use required Filled
- Fenspiride is encountered in historical pharmaceutical records, analytical reference materials and research on substances formerly used for respiratory symptoms.
- Its identity matters when examining legacy medicinal products or studying the cardiac safety concerns associated with its withdrawal.
Sources Filled
- Wikidata item Q518027: fenspiride - identity and sense of the item
- Wikipedia: Fenspiride - general description of the item
Open questions
- Which authoritative CAS and EC identifier mappings distinguish the parent from the hydrochloride and resolve conflicting synonym records?
- Which measured melting or decomposition temperatures, solubilities, pKa values and solid forms are supported by primary evidence for each material form?
- Which validated analytical methods, impurity criteria and stability data support material qualification for the intended use?
- Which primary pharmacology and cardiac studies establish exposure-response relationships, and which mechanistic interpretations remain uncertain?
- What current medicinal, research-supply, import, GHS and occupational-exposure requirements apply in the intended jurisdiction, and where are authoritative values absent?
Machine files
Provenance
thing registry research (pass 2) · unreviewed
Built from: models/things/publications/thing-q518027/spec.json